Delivery Order SPE2DE21D0005-SPE2D625F90RN

Award Date 2/24/25
Potential Completion Date 2/24/25
Potential Value $2.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract, which does not have a set-aside designation, is a Delivery Order for PURAPLY AM XT 4.91X4.91 medical supplies. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies, particularly the Department of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
This federal contract award, with an ID of SPE2DE21D0005|SPE2D625F87GE, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer and regenerative medicine company located in Canton, Massachusetts. The $21,384.00 fixed-price delivery order contract is for the supply of PURAPLY SX 6CM X 9CM medical products, which are likely advanced wound care or tissue regeneration solutions used to support medical treatments across military and veteran healthcare...
This federal contract award is a delivery order (SPE2DE21D0005|SPE2D625F212L) valued at $5,100.00, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is for the supply of PURAPLY AM XT 4.91X4.91, an advanced wound care product. Organogenesis is a leading provider of regenerative medicine solutions to federal healthcare agencies, particularly the Department of Defense (DoD) and Department...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care and surgical biologics products. The contract, valued at $8,150.00, is for the delivery of PURAPLY MZ 500MG, a wound care product. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract, valued at $5,100.00, is for the supply of PURAPLY AM XT 4.91X4.91 medical products. This is not a set-aside contract, indicating Organogenesis competed as a standard commercial vendor. The contract is a fixed-price with economic price...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...
This federal contract award to Organogenesis Inc. is a $2,200.00 fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical for the product PURAPLY AM XT 4.91X4.91. The award has an ultimate completion date of July 5, 2024 and does not utilize a set-aside designation. Organogenesis Inc. is a leading regenerative medicine company that has been awarded numerous contracts with the Department of Defense (DoD) and Department of Veterans Affairs (VA) to supply...
The U.S. Defense Logistics Agency Troop Support Medical has awarded Organogenesis Inc., a leading regenerative medicine company, a $1,118.88 fixed-price delivery order contract for PURAPLY AM (2x2) 4 SQ CM wound dressings. This is not a set-aside contract. Organogenesis is a for-profit manufacturer that has been awarded numerous prime federal contracts to provide wound care products, surgical implants, and tissue regeneration solutions to government agencies, including the Department of...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F90RN
    Delivery Order

This federal contract award SPE2DE21D0005|SPE2D625F90RN, valued at $2,280, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company in Canton, Massachusetts. The contract is for PURAPLY MZ 500MG, a medical supply product, with a fixed-price delivery order and an ultimate completion date of February 24, 2025. Organogenesis is a for-profit manufacturer that specializes in advanced wound care, surgical biologics, and tissue regeneration products, and has established itself as a key supplier of medical products to federal healthcare agencies like the Department of Veterans Affairs (VA) and DLA. This contract award is not associated with a set-aside program. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the VA and DLA, underscoring its strategic position in government medical procurement for regenerative medicine products.

Generated 6/1/25, 3:33 AM